Antibiofilm and Antivirulence Efficacies of Flavonoids and Curcumin Against Acinetobacter baumannii
暂无分享,去创建一个
S. K. Rajasekharan | C. Raorane | Jintae Lee | R. García-Contreras | Jin-Hyung Lee | Yong-Guy Kim | Jin‐Hyung Lee | Yong‐Guy Kim
[1] D. Moser,et al. Antibiofilm efficacy of curcumin in combination with 2-aminobenzimidazole against single- and mixed-species biofilms of Candida albicans and Staphylococcus aureus. , 2019, Colloids and surfaces. B, Biointerfaces.
[2] S. K. Rajasekharan,et al. LED based real-time survival bioassays for nematode research , 2018, Scientific Reports.
[3] Prince Sharma,et al. Curcumin alleviates persistence of Acinetobacter baumannii against colistin , 2018, Scientific Reports.
[4] S. Knight,et al. Structural basis forAcinetobacter baumanniibiofilm formation. , 2018 .
[5] S. Knight,et al. Structural basis for Acinetobacter baumannii biofilm formation , 2018, Proceedings of the National Academy of Sciences.
[6] S. Filler,et al. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection , 2018, PLoS pathogens.
[7] J. Cavanagh,et al. The Structure of the Biofilm-controlling Response Regulator BfmR from Acinetobacter baumannii Reveals Details of Its DNA-binding Mechanism. , 2018, Journal of molecular biology.
[8] P. Mishra,et al. Antimicrobial and antibiofilm activity of curcumin-silver nanoparticles with improved stability and selective toxicity to bacteria over mammalian cells , 2017, Medical Microbiology and Immunology.
[9] Muhammad Saad Khan,et al. Use of Nanoscale Materials for the Effective Prevention and Extermination of Bacterial Biofilms , 2018, Biotechnology and Bioprocess Engineering.
[10] Jintae Lee,et al. Alizarin and Chrysazin Inhibit Biofilm and Hyphal Formation by Candida albicans , 2017, Front. Cell. Infect. Microbiol..
[11] B. Mishra,et al. Curcumin Quantum Dots Mediated Degradation of Bacterial Biofilms , 2017, Front. Microbiol..
[12] M. Bonten,et al. P. aeruginosa colonization at ICU admission as a risk factor for developing P. aeruginosa ICU pneumonia , 2017, Antimicrobial Resistance & Infection Control.
[13] E. Combet,et al. The Anti-Adhesive Effect of Curcumin on Candida albicans Biofilms on Denture Materials , 2017, Front. Microbiol..
[14] S. K. Rajasekharan,et al. Antibiofilm and Anti-β-Lactamase Activities of Burdock Root Extract and Chlorogenic Acid against Klebsiella pneumoniae. , 2017, Journal of microbiology and biotechnology.
[15] I. Rasooli,et al. Filamentous hemagglutinin adhesin FhaB limits A.baumannii biofilm formation. , 2017, Frontiers in bioscience.
[16] Jayme L. Dahlin,et al. The Essential Medicinal Chemistry of Curcumin , 2017, Journal of medicinal chemistry.
[17] Sheela Chandra,et al. Flavonoids: an overview , 2016, Journal of Nutritional Science.
[18] S. Peh,et al. Antibacterial Action of Curcumin against Staphylococcus aureus: A Brief Review , 2016, Journal of tropical medicine.
[19] P. Visca,et al. Acinetobacter baumannii Biofilm Formation in Human Serum and Disruption by Gallium , 2016, Antimicrobial Agents and Chemotherapy.
[20] J. Hardouin,et al. Global Dynamic Proteome Study of a Pellicle-forming Acinetobacter baumannii Strain , 2016, Molecular & Cellular Proteomics.
[21] Yuehua Wu,et al. Biofilm-Related Genes: Analyses in Multi-Antibiotic Resistant Acinetobacter Baumannii Isolates From Mainland China , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[22] T. Umland,et al. The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii , 2016, mSphere.
[23] Chuanfu Zhang,et al. Relationship between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Acinetobacter baumannii , 2016, Front. Microbiol..
[24] E. Mylonakis,et al. Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology , 2015, Antimicrobial Agents and Chemotherapy.
[25] U. H. Stroeher,et al. Identification of genes essential for pellicle formation in Acinetobacter baumannii , 2015, BMC Microbiology.
[26] A. Kumari,et al. Bactericidal Activity of Curcumin I Is Associated with Damaging of Bacterial Membrane , 2015, PloS one.
[27] Li-juan Wu,et al. Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones , 2015, BMC Microbiology.
[28] N. Høiby,et al. Strategies for combating bacterial biofilm infections , 2014, International Journal of Oral Science.
[29] O. Lesouhaitier,et al. Characterisation of Pellicles Formed by Acinetobacter baumannii at the Air-Liquid Interface , 2014, PloS one.
[30] S. Ryu,et al. Stilbenes reduce Staphylococcus aureus hemolysis, biofilm formation, and virulence. , 2014, Foodborne pathogens and disease.
[31] C. Tang,et al. The sensor kinase BfmS mediates virulence in Acinetobacter baumannii. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[32] D. Wareham,et al. In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii , 2014, BMC Microbiology.
[33] Rishan Singh. Determination of Minimum Inhibitory Concentration of Cycloserine in Multidrug Resistant Mycobacterium tuberculosis Isolates , 2014 .
[34] G. Allam,et al. Hesperidin Inhibits Inflammatory Response Induced by Aeromonas hydrophila Infection and Alters CD4+/CD8+ T Cell Ratio , 2014, Mediators of inflammation.
[35] J. Boyce,et al. Biological Cost of Different Mechanisms of Colistin Resistance and Their Impact on Virulence in Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.
[36] Sean D. Stowe,et al. Identification of BfmR, a response regulator involved in biofilm development, as a target for a 2-Aminoimidazole-based antibiofilm agent. , 2012, Biochemistry.
[37] Jintae Lee,et al. Flavone Reduces the Production of Virulence Factors, Staphyloxanthin and α-Hemolysin, in Staphylococcusaureus , 2012, Current Microbiology.
[38] Donoghue,et al. Acinetobacter baumannii , 2012, Virulence.
[39] Karl A. Hassan,et al. Adherence and motility characteristics of clinical Acinetobacter baumannii isolates. , 2011, FEMS microbiology letters.
[40] Jung-Ae Kim,et al. Apple Flavonoid Phloretin Inhibits Escherichia coli O157:H7 Biofilm Formation and Ameliorates Colon Inflammation in Rats , 2011, Infection and Immunity.
[41] R. Bonomo,et al. Genetic analysis of surface motility in Acinetobacter baumannii. , 2011, Microbiology.
[42] S. Zinjarde,et al. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. , 2011, FEMS immunology and medical microbiology.
[43] J. Vila,et al. Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species , 2011, BMC Research Notes.
[44] J. Gaddy,et al. The Opportunistic Human Pathogen Acinetobacter baumannii Senses and Responds to Light , 2010, Journal of bacteriology.
[45] W. Bowen,et al. Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. , 2006, FEMS microbiology letters.
[46] L. Actis,et al. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. , 2003, Microbiology.
[47] G. Beecher,et al. Liquid chromatographic method for the separation and quantification of prominent flavonoid aglycones. , 2000, Journal of chromatography. A.
[48] J. Costerton,et al. Bacterial biofilms: a common cause of persistent infections. , 1999, Science.
[49] A. Schulze,et al. Plasmid DNA fingerprinting of Acinetobacter species other than Acinetobacter baumannii , 1994, Journal of clinical microbiology.
[50] Howard C. Berg,et al. Genetic analysis , 1957, Nature Biotechnology.
[51] T. Wood,et al. Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections. , 2017, International journal of antimicrobial agents.
[52] M. Bonten,et al. Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[53] Clinical,et al. Performance standards for antimicrobial disk and dilution susceptibilty tests for bacteria isolated from animals : approved standard , 2008 .
[54] J. Bryers. Bacterial biofilms. , 1993, Current opinion in biotechnology.